Literature DB >> 23570673

CERAD practice effects and attrition bias in a dementia prevention trial.

Melissa Mathews1, Erin Abner, Allison Caban-Holt, Richard Kryscio, Frederick Schmitt.   

Abstract

BACKGROUND: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) set of tests is frequently used for tracking cognition longitudinally in both clinical and research settings. Repeated cognitive assessments are an important component in measuring such changes; however, practice effects and attrition bias may obscure significant clinical change over time. The current study sought to examine the presence and magnitude of practice effects and the role of attrition bias in a sample of cognitively normal older men enrolled in a prevention trial.
METHOD: Participants were grouped according to whether they completed five years of follow-up (n = 182) or less (n = 126). Practice effects were examined in these participants as a whole (n = 308) and by group.
RESULTS: Findings indicate that moderate practice effects exist in both groups on the CERAD T-score and that attrition bias likely does not play a contributing role in improved scores over time.
CONCLUSION: The current study provides additional evidence and support for previous findings that repeated cognitive assessment results in rising test scores in longitudinally collected data and demonstrates that these findings are unlikely to be due to attrition.

Entities:  

Mesh:

Year:  2013        PMID: 23570673      PMCID: PMC4012228          DOI: 10.1017/S1041610213000367

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  23 in total

1.  Longitudinal analysis of the effects of the aging process on neuropsychological test performance in the healthy young-old and oldest-old.

Authors:  S E Hickman; D B Howieson; A Dame; G Sexton; J Kaye
Journal:  Dev Neuropsychol       Date:  2000       Impact factor: 2.253

2.  Scoring higher the second time around: meta-analyses of practice effects in neuropsychological assessment.

Authors:  Matthew Calamia; Kristian Markon; Daniel Tranel
Journal:  Clin Neuropsychol       Date:  2012-04-30       Impact factor: 3.535

3.  A multicenter evaluation of new treatment efficacy instruments for Alzheimer's disease clinical trials: overview and general results. The Alzheimer's Disease Cooperative Study.

Authors:  S H Ferris; J A Mackell; R Mohs; L S Schneider; D Galasko; P J Whitehouse; F A Schmitt; M Sano; R G Thomas; C Ernesto; M Grundman; K Schafer; L J Thal
Journal:  Alzheimer Dis Assoc Disord       Date:  1997       Impact factor: 2.703

4.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery.

Authors:  K A Welsh; N Butters; R C Mohs; D Beekly; S Edland; G Fillenbaum; A Heyman
Journal:  Neurology       Date:  1994-04       Impact factor: 9.910

5.  Category fluency in mild cognitive impairment: reduced effect of practice in test-retest conditions.

Authors:  D B Cooper; L H Lacritz; M F Weiner; R N Rosenberg; C M Cullum
Journal:  Alzheimer Dis Assoc Disord       Date:  2004 Jul-Sep       Impact factor: 2.703

Review 6.  The selenium and vitamin E cancer prevention trial.

Authors:  Eric A Klein; Scott M Lippman; Ian M Thompson; Phyllis J Goodman; Demetrius Albanes; Philip R Taylor; Charles Coltman
Journal:  World J Urol       Date:  2003-03-08       Impact factor: 4.226

7.  Estimating premorbid intelligence in African-American and white elderly veterans using the American version of the National Adult Reading Test.

Authors:  J R Boekamp; M E Strauss; N Adams
Journal:  J Clin Exp Neuropsychol       Date:  1995-10       Impact factor: 2.475

8.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease.

Authors:  J C Morris; A Heyman; R C Mohs; J P Hughes; G van Belle; G Fillenbaum; E D Mellits; C Clark
Journal:  Neurology       Date:  1989-09       Impact factor: 9.910

9.  Designing a large prevention trial: statistical issues.

Authors:  Richard J Kryscio; Marta S Mendiondo; Frederick A Schmitt; William R Markesbery
Journal:  Stat Med       Date:  2004-01-30       Impact factor: 2.373

10.  A new rating scale for Alzheimer's disease.

Authors:  W G Rosen; R C Mohs; K L Davis
Journal:  Am J Psychiatry       Date:  1984-11       Impact factor: 18.112

View more
  15 in total

1.  Longitudinal Change in Performance on the Montreal Cognitive Assessment in Older Adults.

Authors:  Sarah A Cooley; Jodi M Heaps; Jacob D Bolzenius; Lauren E Salminen; Laurie M Baker; Staci E Scott; Robert H Paul
Journal:  Clin Neuropsychol       Date:  2015-09-16       Impact factor: 3.535

2.  Association of Antioxidant Supplement Use and Dementia in the Prevention of Alzheimer's Disease by Vitamin E and Selenium Trial (PREADViSE).

Authors:  Richard J Kryscio; Erin L Abner; Allison Caban-Holt; Mark Lovell; Phyllis Goodman; Amy K Darke; Monica Yee; John Crowley; Frederick A Schmitt
Journal:  JAMA Neurol       Date:  2017-05-01       Impact factor: 18.302

3.  Anticholinergic exposure and cognitive decline in older adults: effect of anticholinergic exposure definitions in a 3-year analysis of the multidomain Alzheimer preventive trial (MAPT) study.

Authors:  Laurine Andre; Adeline Gallini; François Montastruc; Nicola Coley; Jean-Louis Montastruc; Bruno Vellas; Sandrine Andrieu; Virginie Gardette
Journal:  Br J Clin Pharmacol       Date:  2018-10-17       Impact factor: 4.335

4.  Self-Reported Memory Complaints: A Comparison of Demented and Unimpaired Outcomes.

Authors:  R J Kryscio; E L Abner; G A Jicha; P T Nelson; C D Smith; L J Van Eldik; W Lou; D W Fardo; G E Cooper; F A Schmitt
Journal:  J Prev Alzheimers Dis       Date:  2016-03

5.  Baseline subjective memory complaints associate with increased risk of incident dementia: the PREADVISE trial.

Authors:  E L Abner; R J Kryscio; A M Caban-Holt; F A Schmitt
Journal:  J Prev Alzheimers Dis       Date:  2015-03

Review 6.  Hippocampal Sclerosis of Aging Can Be Segmental: Two Cases and Review of the Literature.

Authors:  Eseosa T Ighodaro; Gregory A Jicha; Frederick A Schmitt; Janna H Neltner; Erin L Abner; Richard J Kryscio; Charles D Smith; Taylor Duplessis; Sonya Anderson; Ela Patel; Adam Bachstetter; Linda J Van Eldik; Peter T Nelson
Journal:  J Neuropathol Exp Neurol       Date:  2015-07       Impact factor: 3.685

7.  Improving power in small-sample longitudinal studies when using generalized estimating equations.

Authors:  Philip M Westgate; Woodrow W Burchett
Journal:  Stat Med       Date:  2016-04-18       Impact factor: 2.373

8.  Transcranial ultrasound pulse stimulation reduces cortical atrophy in Alzheimer's patients: A follow-up study.

Authors:  Tudor Popescu; Cyril Pernet; Roland Beisteiner
Journal:  Alzheimers Dement (N Y)       Date:  2021-02-25

9.  Assessing the discriminant ability, reliability, and comparability of multiple short forms of the Boston Naming Test in an Alzheimer's disease center cohort.

Authors:  Yuriko Katsumata; Melissa Mathews; Erin L Abner; Gregory A Jicha; Allison Caban-Holt; Charles D Smith; Peter T Nelson; Richard J Kryscio; Frederick A Schmitt; David W Fardo
Journal:  Dement Geriatr Cogn Disord       Date:  2015-01-21       Impact factor: 3.346

10.  Neural substrates of cognitive subtypes in Parkinson's disease: a 3-year longitudinal study.

Authors:  Yumiko Shoji; Yoshiyuki Nishio; Toru Baba; Makoto Uchiyama; Kayoko Yokoi; Toshiyuki Ishioka; Yoshiyuki Hosokai; Kazumi Hirayama; Hiroshi Fukuda; Masashi Aoki; Takafumi Hasegawa; Atsushi Takeda; Etsuro Mori
Journal:  PLoS One       Date:  2014-10-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.